Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mycoses ; 64(5): 569-572, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-33480122

RESUMO

BACKGROUND: The body of evidence on cutaneous mucormycosis is largely derived from case reports or single-centre databases. OBJECTIVES: Our study aimed to describe incidence, predisposing factors and inpatient outcomes of cutaneous mucormycosis in the United States. METHODS: We conducted a population-based retrospective study using the National Inpatient Sample 2016-17 data. Fifty-six discharges had a diagnosis of cutaneous mucormycosis on the International Classification of Diseases, tenth revision. Descriptive analysis was performed for the demographics, predisposing factors, length of stay (LOS), cost and inpatient mortality. The NIS represents 20% of all discharges in the United States, which allowed us to estimate the national incidence of cutaneous mucormycosis. RESULTS: An estimated total of 280 admissions occurred between 2016 and 2017, indicating 3.9 cases per million admissions across the United States. The estimated incidence rate was 0.43 cases per million people per year. Median age was 49.5 (19-59) years, 44.6% were female, and 54.9% were Caucasian. We identified haematologic malignancies (48.2%) and solid organ transplantations (10.7%), often accompanied by skin/soft tissue or post-procedural infections, were the most common predisposing conditions. Median LOS was 15 (6-31) days, median total charges were 187,030 (65,962-446,265) USD, and in-hospital mortality rate was 16.1%. CONCLUSIONS: In current clinical practice, physicians may encounter cutaneous mucormycosis most commonly in severely immunocompromised hosts with haematologic malignancies or transplantations, accompanied by skin/soft tissue or post-procedural infections. A high index of suspicion and prompt tissue sampling in at-risk groups is important to improve the outcomes.


Assuntos
Causalidade , Incidência , Mucormicose/epidemiologia , Pele/microbiologia , Resultado do Tratamento , Adulto , Feminino , Humanos , Hospedeiro Imunocomprometido , Pacientes Internados/estatística & dados numéricos , Leucemia/complicações , Masculino , Pessoa de Meia-Idade , Mortalidade , Mucor/isolamento & purificação , Mucor/patogenicidade , Mucormicose/etiologia , Transplante de Órgãos/efeitos adversos , Estudos Retrospectivos , Pele/patologia , Estados Unidos/epidemiologia , Adulto Jovem , Zigomicose/epidemiologia
2.
Langmuir ; 29(26): 8377-84, 2013 Jul 02.
Artigo em Inglês | MEDLINE | ID: mdl-23745578

RESUMO

Gallium nitride is a wide band gap semiconductor that demonstrates a unique set of optical and electrical properties as well as aqueous stability and biocompatibility. This combination of properties makes gallium nitride a strong candidate for use in chemical and biological applications such as sensors and neural interfaces. Molecular modification can be used to enhance the functionality and properties of the gallium nitride surface. Here, gallium nitride surfaces were functionalized with a PC12 cell adhesion promoting peptide using covalent and affinity driven attachment methods. The covalent scheme proceeded by Grignard reaction and olefin metathesis while the affinity driven scheme utilized the recognition peptide isolated through phage display. This study shows that the method of attaching the adhesion peptide influences PC12 cell adhesion and differentiation as measured by cell density and morphological analysis. Covalent attachment promoted monolayer and dispersed cell adhesion while affinity driven attachment promoted multilayer cell agglomeration. Higher cell density was observed on surfaces modified using the recognition peptide. The results suggest that the covalent and affinity driven attachment methods are both suitable for promoting PC12 cell adhesion to the gallium nitride surface, though each method may be preferentially suited for distinct applications.


Assuntos
Materiais Biocompatíveis/química , Gálio/química , Oligopeptídeos/química , Sequência de Aminoácidos , Animais , Materiais Biocompatíveis/farmacologia , Adesão Celular/efeitos dos fármacos , Contagem de Células , Gálio/farmacologia , Microscopia de Força Atômica , Dados de Sequência Molecular , Células PC12 , Espectroscopia Fotoeletrônica , Ratos , Propriedades de Superfície
3.
Langmuir ; 29(1): 216-20, 2013 Jan 08.
Artigo em Inglês | MEDLINE | ID: mdl-23227805

RESUMO

The stability of III-nitride semiconductors in various solutions becomes important as researchers begin to integrate them into sensing platforms. This study quantitatively compares the stability of GaN surfaces with different polarities. This type of quantification is important because it represents the first step toward designing semiconductor material interfaces compatible with solution conditions. A stability study of Ga- and N-polar GaN was conducted by immersion of the surfaces in deionized H(2)O, pH 5, pH 9, and H(2)O(2) solutions for 7 days. Inductively coupled plasma mass spectrometry of the solutions was conducted to determine the amount of gallium leached from the surface. X-ray photoelectron spectroscopy and atomic force microscopy were used to compare the treated surfaces to untreated surfaces. The results show that both gallium nitride surface types exhibit the greatest stability in acidic and neutral solutions. Gallium polar surfaces were found to exhibit superior stability to nitrogen polar surfaces in the solutions studied. Our findings highlight the need for further research on surface passivation and functionalization techniques for polar III-nitride semiconductors.


Assuntos
Gálio/química , Água/química , Estabilidade de Medicamentos , Microscopia de Força Atômica , Espectroscopia Fotoeletrônica , Semicondutores
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...